Gilead Sciences, Inc. (GILD)
125.45
-2.65
(-2.07%)
USD |
NASDAQ |
Jun 09, 16:00
125.01
-0.44
(-0.35%)
After-Hours: 20:00
Gilead Sciences SG&A Expense (Quarterly) : 1.451B for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Biogen, Inc. | 607.30M |
| AbbVie, Inc. | 3.578B |
| Amgen, Inc. | 1.602B |
| Johnson & Johnson | 6.034B |
| Eli Lilly & Co. | 2.934B |